ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
118.041 IP-LS
Project title
Exploring the potential of short-acting immune checkpoint blockers in the therapy of sepsis

Participants

Research organisation: Innosuisse
Swiss Innovation Agency
Einsteinstrasse 2
CH-3003 Bern
+41 58 461 61 61 (Call Center)
info@innosuisse.ch
www.innosuisse.ch/
Contact person

 Freigang Stefan
Universität Bern

Scientific management
Universität Bern

Implementation Partner


Combioxin SA
www.uid.admin.ch/Detail.aspx?uid_id=CHE310572972